ArticleBMC plant biology2025
Synergistic effects of Vachellia nilotica-derived zinc oxide nanoparticles and melatonin on drought tolerance in Fragaria × ananassa.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Enhancing the yield and berry color of crimson seedless table grape variety (Vitis vinifera L.) via zinc oxide nanoparticles integrated with molasses.BMC plant biology · 2026Article
- Eco-Physiological and Molecular Roles of Zinc Oxide Nanoparticles (ZnO-NPs) in Mitigating Abiotic Stress: A Comprehensive Review.Plants (Basel, Switzerland) · 2026Review
- Efficacy of zinc oxide nanoaciculates as antagonists against Meloidogyne javanica on Phaseolus abyssinicus.Scientific reports · 2025Article
- Impact of Hydrothermal Treatment on the Bioactive Compounds of Different Brown Rice Varieties in India.Applied biochemistry and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the synergistic effects of zinc oxide nanoparticles (ZnO NPs) and melatonin (MT) on Fragaria × ananassa (strawberry) plants under drought stress, focusing on growth, fruit biomass, and stress tolerance. ZnO NPs enhance nutrient uptake and stress resistance, while MT regulates growth hormones and boosts photosynthetic efficiency. Seven treatments were evaluated: T1 (no stress, 0.5 g/L ZnO NPs + 0.1 g/L MT), T2 (no stress, 0.5 g/L ZnO NPs), T3 (no stress, 0.1 g/L MT), T4 (drought stress, no application), T5 (drought stress, 0.5 g/L ZnO NPs + 0.1 g/L MT), T6 (drought stress, 0.5 g/L ZnO NPs), and T7 (drought stress, 0.1 g/L MT). Growth and stress parameters included shoot/root length, fruit biomass, bud number, chlorophyll content, oxidative stress markers (H₂O₂, MDA), and antioxidant enzyme activities in the leaves of Fragaria × ananassa. The combined treatment (ZnO NPs + MT) consistently outperformed others, achieving the highest growth metrics under both conditions: shoot length (22.33 ± 1.53 cm non-stress, 15.00 ± 1.53 cm drought), root length (18.67 ± 1.53 cm non-stress, 12.00 ± 1.53 cm drought), and fruit biomass (9.55 ± 0.31 g non-stress, 5.02 ± 0.23 g drought). Bud formation peaked at 3.33 ± 0.58 buds/plant non-stress and 2.00 ± 0.00 buds/plant drought. Under drought, the combined treatment also enhanced chlorophyll content (2.47 ± 0.20 mg/g FW) and significantly reduced H₂O₂ (28.67 ± 2.52 µmol/g FW) and MDA (4.21 ± 0.10 µmol/g FW) levels, while maximizing antioxidant enzyme activities (SOD: 121.67 ± 7.64 U/g FW, POD: 206.33 ± 14.84 U/g FW, CAT: 48.00 ± 3.61 U/g FW). These findings highlight the combined application of ZnO NPs and MT as a promising strategy to enhance growth and stress tolerance in strawberry plants, warranting further research on optimized concentrations, delivery methods, and molecular mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.